Quinaprilat Inhibitor

MBS5756623 is an inhibitor targeting Quinaprilat. Quinaprilat inhibits angiotensin converting enzyme.

Sun S, Wei Y, Wang H, Cao Y, Deng B. A novel electrochemiluminescence sensor coupled with capillary electrophoresis for simultaneous determination of quinapril hydrochloride and its metabolite quinaprilat hydrochloride in human plasma. Talanta. 2018 Mar 1;179:213-220. doi: 10.1016/j. Talanta.2017.10.050. Epub 2017 Nov 4. PubMed PMID: 29310224.
Wojewodzka-Zelezniakowicz M, Gromotowicz-Poplawska A, Kisiel W, Konarzewska E, Szemraj J, Ladny JR, Chabielska E. Angiotensin-converting enzyme inhibitors attenuate propofol-induced pro-oxidative and antifibrinolytic effect in human endothelial cells. J Renin Angiotensin Aldosterone Syst. 2017 Jan;18(1):1470320316687197. doi: 10.1177/1470320316687197. PubMed PMID: 28090801; PubMed Central PMCID: PMC5843862.

Small volumes of Quinaprilat, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.